RE: ASCO30 May 2025 14:55
ASCO is the pinnacle of global cancer research, where the most impactful breakthroughs in oncology are unveiled. Being selected to present there places a company or research team alongside the world’s leading innovators in cancer treatment and diagnostics. It’s not just validation—it’s a powerful endorsement by top clinical experts that the data is credible, meaningful, and potentially practice-changing.
For diagnostics like liquid biopsies, ASCO exposure can accelerate clinical adoption, especially by major health systems like the NHS or private payers. For therapies, it often signals clear survival or safety benefits over existing treatments.
ASCO draws global media, regulators, investors, and Big Pharma—making it a key event for commercial visibility and strategic partnerships. A plenary or oral presentation is especially prestigious, typically reserved for breakthrough results that could reshape clinical practice.